Impact of Pentadecapeptide BPC 157 on Muscle Healing Impaired by Systemic Corticosteroid Application
20 Parkinsons disease: A small study of patients with early, untreated Parkinsons disease given high-dose intravenous glutathione twice a day for 30 days showed symptom improvement that lasted for 24 months after treatment ended
That's the principle Strive operates on, and we're not moving off it
Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: A comparison with bone marrow and autologous cortical bone implantation
The ban focuses on peptide hormones, growth factors, and related substances that have performance-enhancing potential or are not approved for human use
Topical GHK-Cu is excellent for localized skin and hair concerns, while subcutaneous injections or IV therapy offer higher bioavailability for systemic recovery, organ support, and deep tissue repair